• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Breakthrough synthesis strategy could mean wave of new medicinal compounds

Bioengineer by Bioengineer
July 3, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Benjamin Moten

TALLAHASSEE, Fla. — In pharmacology, not all molecular structures are created equal. Some frameworks are overrepresented in nature, making them especially attractive to scientists on the hunt for more effective drugs.

One such structure, known to scientists as the carbocyclic 5-8-5 fused ring system, is notoriously difficult to produce using conventional laboratory methods, and researchers have therefore been largely unable to tap into its potentially broad therapeutic potential.

Now, an innovative synthetic technique developed by Florida State University chemists could unlock these elusive structures, opening the door to a new world of cutting-edge medicinal compounds.

In a study published in the journal Chemical Science, FSU researchers detail a novel, modular scheme for producing large quantities of the 5-8-5 ring structure. A synthesis process that was once exceptionally labor- and resource-intensive, they discovered, could be streamlined into four relatively straightforward steps.

"The ubiquity of the 5-8-5 ring system within natural products caught our attention," said lead author James Frederich, an assistant professor in the Department of Chemistry and Biochemistry. "Our chemistry provides an attractive entry point to natural products harboring a 5-8-5 ring system."

Considered by chemists to be a possible example of a "privileged scaffold" — an atomic arrangement that recurs frequently in biologically active compounds — the 5-8-5 framework is composed of two five-sided molecular rings fused to a central 8-sided ring. This unique architecture constitutes the core of more than 30 natural products, several of which have useful, potentially therapeutic effects in human cell cultures.

Existing methods for producing this framework in a lab were limited by impractically protracted synthesis processes requiring high temperatures and transition metal catalysts. Frederich's approach sidesteps these hurdles. In his system, cyclization substrates — the underlying structures upon which the ring frameworks are built — can be accessed via a simple two-step assembly scheme. With a reliable substrate in place, the full 5-8-5 scaffold is accomplished in one, highly controlled operation with UV light employed to promote ring formation.

"The use of UV light is particularly convenient as it avoids the need for high temperatures or costly catalysts," Frederich said.

Frederich's strategy is a significant improvement on current approaches to 5-8-5 ring structure synthesis. He said the simplified, high-yielding methodology will aid scientists as they work to better understand the possible medicinal properties of synthetic products built upon the 5-8-5 scaffold.

In particular, Frederich said these compounds could help stabilize protein-protein interactions — the physical mingling of protein molecules that govern biological processes within a cell.

"We speculate that the 5-8-5 ring system can support a range of designed, non-natural structures with interesting properties in human cell culture," he said. "We expect to leverage this chemistry to build and test certain structures that have been shown to modulate protein-protein interactions."

###

This research was funded by the National Institutes of Health.

Media Contact

Zack Boehm
[email protected]
850-645-1504
@floridastate

http://www.fsu.edu

Original Source

http://news.fsu.edu/news/science-technology/2018/07/03/breakthrough-synthesis-strategy-could-mean-wave-of-new-medicinal-compounds/ http://dx.doi.org/10.1039/C8SC00999F

Share12Tweet7Share2ShareShareShare1

Related Posts

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.